News

InflammaSkin® application presented by Incospharm at the Gordon Research Conference (GRC) on Barrier Function of Mammalian Skin Incospharm is presenting a poster showing one application of our live human psoriasis model, InflammaSkin® at the GRC held in New Hampshire from August 11th to August 16th. InflammaSkin®, testing of innovative anti-inflammatory drugs Poster title: "ICP-5249 reduces dermal inflammatory signaling through autophagy activation" IncospharmRead more

Genoskin will attend the BIO International Convention in Philadelphia, PA The BIO International Convention is a global event regrouping biotech and pharma leaders over intensive networking. The convention is a great opportunity to discuss a wide spectrum of life science and application areas including drug discovery, bio manufacturing, genomics, biofuels, nanotechnology or cell therapy. This year more than 16,000 attendeesRead more

SID2019: Genoskin validates skin integrity and metabolism at 10 days with Promega Glucose-Glo™ and Lac­tate-Glo™ Assays Genoskin’s team of skin experts will be presenting its latest work at the 77th SID Annual Meeting from May 8 to May 11 in Chicago. To learn more about our live human skin models and R&D services, swing by booth #106. Our Chief CommercialRead more

Genoskin to attend the 77th Annual Meeting of the Society for Investigative Dermatology  The 77th Annual Meeting of the Society for Investigative Dermatology (SID2019) is a knowledge hub that connects a diverse group of senior researchers, clinicians and clinical trainees. The SID Meeting appears as a premier forum for the exchange of knowledge in various disciplines, from Dermatology and ImmunologyRead more

Genoskin presents its subcutaneous injection model HypoSkin® at New Frontiers in 3D Genoskin’s CEO Pascal Descargues, PhD will attend scientific symposium New Frontiers in 3D at the MIT Samberg Center in Cambridge, MA, USA. Take the opportunity to discover our unique subcutaneous injection model through a poster presentation.   Hyposkin®, a unique human skin model to study subcutaneous injection PosterRead more

Genoskin presents unique subcutaneous injection model at SOT Baltimore The Genoskin team spreads its wings: in March, you'll find us at the Society of Toxicology's Annual Meeting in Baltimore, US, where we'll present our new HypoSkin model to test the efficacy and toxicity of subcutaneous injections on live human skin models.   Unique tools to test human skin response to allRead more